Amgen establishes a corporate lab at Mila, as the partnership between the two organizations grows
MONTREAL, QC, (January 18, 2023) - Amgen, one of the world’s leading biotechnology companies, and Mila – Quebec Artificial Intelligence Institute, today announced the expansion of their partnership aimed at further transforming Artificial Intelligence (AI) guided drug development. As part of this evolution, Amgen is establishing a corporate laboratory within Mila’s headquarters where scientists from both organizations will interact and engage. Amgen and Mila have also agreed to collaborate on specific projects to enhance the way that machine learning is applied to the discovery and development of biologic therapeutics, projects in which Professor Yoshua Bengio, founder and scientific director of Mila, will participate. This announcement extends the partnership between the two organizations that began in 2021.